About The Study: This analysis of 1,977 clinical trials investigating therapeutics and vaccines for COVID-19 found that most were funded by public sources (58%), followed by industry (27%) and public-private partnerships (15%). Most of these clinical trials focused on COVID-19 therapeutics (85%) as opposed to vaccines (15%).
Authors: Elias Mossialos, Ph.D., of the London School of Economics and Political Science, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2022.26892)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.26892?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081622
About JAMA Network Open : JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
JAMA Network Open